IPRAMID 250mcg/ml RESPIRATORY SOLUTION contains Ipratropium Bromide 250 mcg/ml. It is an anticholinergic bronchodilator used for inhalation to relieve bronchospasm and improve breathing in patients with obstructive airway diseases.
Uses:
Treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).
Relief of wheezing and shortness of breath.
Adjunct treatment of bronchial asthma.
Helps improve airflow by relaxing the airway muscles.
Dose:
Adults and children: Usually 250–500 mcg by nebulization 3–4 times daily, or as directed by a physician.
Use the respiratory solution only with a nebulizer as instructed by a healthcare professional.
Dose and duration depend on the patient's condition and response to treatment.